[1] |
刘波. 临床患者深部真菌感染菌群分布情况及耐药性分析[J]. 中国当代医药,2017,24(3):135-137.
|
[2] |
KIM J Y.Human fungal pathogens:why should we learn?[J]. J Microbiol,2016,54(3):145-148.
|
[3] |
周祥文,汪勇军,吴先华. 深部真菌感染的病原菌分布及药敏分析[J]. 中华医院感染学杂志,2014,24(3):596-598.
|
[4] |
黄燕,陈玉坤,冀旭峰,等. ICU患者深部真菌感染的病原菌分布及耐药性分析[J]. 吉林大学学报(医学版),2017,43(1):111-114.
|
[5] |
茅国峰,何秋丽,沈少卿. 无菌体液感染真菌的分布及耐药性检测[J]. 中华实验和临床感染病杂志(电子版),2015,9(2):265-268.
|
[6] |
OSMAN M O,JENSEN S L.Acute pancreatitis:the pathophysiological role of cytokines and integrins. New trends for treatment?[J] . Dig Surg,1999,16(5):347-362.
|
[7] |
MOODY F G,HALEY-RUSSELL D,MUNCY D M.Intestinal transit and bacterial translocation in obstructive pancreatitis[J]. Dig Dis Sci,1995,40(8):1798-1804.
|
[8] |
HAGIHARA M,KASAI H,UMEMURA T,et al.Pharmacokinetic-pharmacodynamic study of itraconazole in patients with fungal infections in intensive care units[J]. J Infect Chemother,2011,17(4):224-230.
|
[9] |
MAY R C,STONE N R,WIESNER D L,et al.Cryptococcus:from environmental saprophyte to global pathogen[J]. Nat Rev Microbiol,2016,14(2):106-117.
|
[10] |
周晓明. 抗真菌药物及其临床应用进展[J]. 中国药业,2014,23(14):117-119.
|
[11] |
YAO Z W,LU X,SHEN C,et al.Comparison of flucytosine and fluconazole combined with amphotericin B for the treatment of HIV-associated cryptococcal meningitis:a systematic review and meta-analysis[J]. Eur J Clin Microbiol Infect Dis,2014,33(8):1339-1344.
|
[12] |
宋晓玲. 新型隐球菌性脑膜炎三种治疗方案的临床疗效研究[J]. 临床医药文献电子杂志,2017,4(50):9745-9747.
|
[13] |
张树敬,杨帆. 棘白菌素类药物[J]. 中国感染与化疗杂志,2012,12(5):393-396.
|
[14] |
王璐璐,刘慧,戴亮. 2013—2015年南京地区常用抗真菌药利用分析[J]. 中国药师,2017,20(2):317-320.
|